Clinical trial Recruiting at 1 site Observational Ages 18 and up

D-RSBI vs RSBI to predict weaning success in COPD patients

Official title: Diaphragmatic Rapid Shallow Breathing Index (D-RSBI) Versus Traditional Rapid Shallow Breathing Index (RSBI) for Prediction of Weaning Success From Mechanical Ventilation in COPD Patients

Run by Sohag University · NCT07590362 · Data updated 2026-11-12

This study tests whether diaphragmatic rapid shallow breathing index (D-RSBI) can better predict which COPD patients on mechanical ventilation will successfully wean than the traditional RSBI.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorSohag University
Academic / other
Locations1 site (Sohag, Sohag Governorate)
StatusRecruiting
StartedApril 15, 2026
Main results expectedMay 2027
Study endsJune 2027
Registry record updatedMay 15, 2026
Trial IDNCT07590362 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Mechanically ventilated COPD patients who are ready for spontaneous breathing trials and meet the stated inclusion criteria.

Probably not a fit

Patients with diaphragmatic pathology, neuromuscular disease, or poor ultrasound windows may not benefit from D-RSBI assessment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational cohort compares two weaning indices—D-RSBI measured by diaphragmatic ultrasound and the traditional RSBI—in COPD patients undergoing spontaneous breathing trials. Participants are mechanically ventilated for more than 24 hours and meet standard readiness criteria, with diaphragmatic ultrasound performed during SBTs and follow-up for 72 hours after extubation to determine weaning outcomes. The study is conducted at Sohag University Hospital, with data collected on predictor accuracy and timing to successful extubation. Inclusion requires stable hemodynamics, adequate oxygenation, and the ability to initiate spontaneous breathing; exclusions include neuromuscular disorders, diaphragmatic pathology, or poor ultrasound windows.

Why it matters

Potential benefit: If successful, D-RSBI could provide a more accurate predictor of weaning readiness, potentially reducing ventilation time and associated risks.

How similar studies have gone: Prior work on diaphragmatic ultrasound and weaning indices has shown promise, but direct head-to-head comparisons like this are limited in COPD populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Mechanically ventilated COPD patients fulfilling standard weaning readiness criteria.
* Invasive mechanical ventilation for more than 24 hours before spontaneous breathing trial.
* Hemodynamically stable without significant vasopressor support.
* Adequate oxygenation with FiO2 ≤ 0.5 and PEEP ≤ 8 cmH2O .
* Preserved mental status and ability to initiate spontaneous breathing.
* Successful tolerance of spontaneous breathing trial conducted on CPAP mode with pressure support ≤ 8 cmH2O.

Exclusion Criteria:

* Refusal of consent
* Neuromuscular disease, phrenic nerve palsy, or diaphragmatic paralysis.
* Large pneumothorax or pathology interfering with ultrasound assessment.
* Terminal extubation.
* Recent major thoracic surgery.
* Poor sonographic window despite repeated attempts.

Where it's running

  • Sohag University Hospital
    Sohag, Sohag Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.